Qulipta vs Gabapentin
A side-by-side look at two neurology medications advertised on TV. Informational only — not medical advice.
| US Qulipta | US Gabapentin | |
|---|---|---|
| Generic name | atogepant | gabapentin |
| Drug class | CGRP Receptor Antagonist | Anticonvulsant / Nerve Pain Agent |
| Treats | Migraine prevention | Nerve pain, seizures |
| Category | Neurology | Neurology |
| Manufacturer | AbbVie | Various (generic) |
| Year approved | 2021 | 1993 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $120M | $1M |
| Common side effects | Nausea, Constipation, Fatigue, Decreased appetite | Drowsiness, Dizziness, Swelling, Coordination problems |
Gabapentin
Frequently asked questions
Is Qulipta or Gabapentin better?
Neither is universally "better." Qulipta (atogepant) and Gabapentin (gabapentin) are both used for neurology, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Qulipta and Gabapentin?
Qulipta is a CGRP Receptor Antagonist made by AbbVie, while Gabapentin is a Anticonvulsant / Nerve Pain Agent made by Various (generic). See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Qulipta has the larger estimated TV advertising budget of the two.